These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37563671)

  • 61. Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N; van Wely M; Vandekerckhove P; Lilford R; van Der Veen F
    Cochrane Database Syst Rev; 2000; (2):CD000412. PubMed ID: 10796718
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
    Siddiqui S; Mateen S; Ahmad R; Moin S
    J Assist Reprod Genet; 2022 Nov; 39(11):2439-2473. PubMed ID: 36190593
    [TBL] [Abstract][Full Text] [Related]  

  • 63. FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome.
    Ewens KG; Jones MR; Ankener W; Stewart DR; Urbanek M; Dunaif A; Legro RS; Chua A; Azziz R; Spielman RS; Goodarzi MO; Strauss JF
    PLoS One; 2011 Jan; 6(1):e16390. PubMed ID: 21283731
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
    Cui L; Li G; Zhong W; Bian Y; Su S; Sheng Y; Shi Y; Wei D; Zhang W; Zhao H; Chen ZJ
    Hum Reprod; 2015 Mar; 30(3):732-6. PubMed ID: 25586784
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of ovarian and metabolic effects of GnRH modulators in two rat models of polycystic ovary syndrome.
    Patel R; Shah G
    Mol Reprod Dev; 2018 Oct; 85(10):778-789. PubMed ID: 30203897
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
    Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS
    Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biochemical Characterization and Molecular Determination of Estrogen Receptor-α (ESR1 PvuII-rs2234693 T>C) and MiRNA-146a (rs2910164 C>G) Polymorphic Gene Variations and Their Association with the Risk of Polycystic Ovary Syndrome.
    Mir R; Tayeb FJ; Barnawi J; Jalal MM; Saeedi NH; Hamadi A; Altayar MA; Alshammari SE; Mtiraoui N; Ali ME; Duhier FMA; Ullah MF
    Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270805
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dopamine might not be involved in the pathogenesis of polycystic ovary syndrome.
    Ferriani RA; Silva de Sá MF; Moura MD; Moreira AC; Gomes UA
    Gynecol Endocrinol; 1989 Dec; 3(4):317-27. PubMed ID: 2516707
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Family association study between melatonin receptor gene polymorphisms and polycystic ovary syndrome in Han Chinese.
    Song X; Sun X; Ma G; Sun Y; Shi Y; Du Y; Chen ZJ
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():108-112. PubMed ID: 26519818
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relationship between leptin receptor and polycystic ovary syndrome.
    Li L; Lee KJ; Choi BC; Baek KH
    Gene; 2013 Sep; 527(1):71-4. PubMed ID: 23769971
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neurotransmitter alteration in a testosterone propionate-induced polycystic ovarian syndrome rat model.
    Chaudhari NK; Nampoothiri LP
    Horm Mol Biol Clin Investig; 2017 Feb; 29(2):71-77. PubMed ID: 27802175
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prolactin secretion in polycystic ovary syndrome (PCOS).
    Szosland K; Pawlowicz P; Lewiński A
    Neuro Endocrinol Lett; 2015; 36(1):53-8. PubMed ID: 25789595
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN; Peng JL; Yang J; Xu WM
    Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pathological pulses in PCOS.
    Coyle C; Campbell RE
    Mol Cell Endocrinol; 2019 Dec; 498():110561. PubMed ID: 31461666
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring: a population-based cohort study.
    Chen X; Koivuaho E; Piltonen TT; Gissler M; Lavebratt C
    Hum Reprod; 2021 Jul; 36(8):2345-2357. PubMed ID: 34046665
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.
    Saxena R; Bjonnes AC; Georgopoulos NA; Koika V; Panidis D; Welt CK
    Hum Reprod; 2015 Jul; 30(7):1697-703. PubMed ID: 25994816
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pro12Ala and His447His polymorphisms of PPAR-gamma are associated with polycystic ovary syndrome.
    Gu BH; Baek KH
    Reprod Biomed Online; 2009 May; 18(5):644-50. PubMed ID: 19549442
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial.
    Zheng X; Guo W; Zeng L; Zheng D; Yang S; Xu Y; Wang L; Wang R; Mol BW; Li R; Qiao J
    Hum Reprod; 2022 Jan; 37(2):242-253. PubMed ID: 34849920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.